BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 4, 2018
View Archived Issues
Breathing control can be restored long after SCI
Read More
Gene therapy rewires brain in PD
Read More
Abrogating androgen axis of evil
Read More
FIT free lunch
Read More
Lilly opens phase II study of LY-3209590 for type 2 diabetes
Read More
Faron receives regulatory approval to initiate first-in-human MATINS study of Clevegen
Read More
Primary endpoint met in phase II study of tradipitant in patients with gastroparesis
Read More
Preclinical data support potential of CAP-1160 for treatment and prevention of cataracts
Read More
KIN-8193, a selective and potent HCK inhibitor, overcomes ibrutinib resistance in B-cell lymphoma
Read More
FDA clears Fate Therapeutics to begin clinical trial of iPSC-derived FT-500
Read More
Novel model of acute repetitive seizures in mice
Read More
Turnstone Biologics reveals vaccinia oncolytic viral immunotherapy platform
Read More
Bristol-Myers Squibb presents phase I results for BMS-986115
Read More
First-in-human phase I study reveals potent antitumor activity of AMG-420 against R/R MM
Read More
BenevolentAI Bio presents new orexin OX2 receptor antagonists
Read More
Nanjing Sanhome Pharmaceutical discloses FGFR-4 inhibitors
Read More
Bristol-Myers Squibb patents IDO1 inhibitors
Read More
Celon Pharma Sp zoo divulges JAK1 and JAK3 inhibitors
Read More
AstraZeneca synthesizes mutant KRAS inhibitors
Read More
NYX-2925 shows promising effects in patients with fibromyalgia
Read More
Progenics begins phase III trial of PyL imaging agent to detect prostate cancer
Read More
Chinese researchers present phase I data for JWCAR-029 in B-cell non-Hodgkin's lymphoma
Read More
ASH 2018: Multiple studies give new insights into clotting cascade
Read More
FDA clears IND for first-in-human trial of QR-421a in patients with Usher syndrome type 2
Read More
Novartis initiates phase III trials of ligelizumab for chronic spontaneous urticaria
Read More
Wakamoto announces Japanese phase III trial of WP-1303 for glaucoma and ocular hypertension
Read More